{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-005757","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2023-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.356689+00:00","generated_at":"2026-06-19T04:44:31.813607+00:00","sec_items":["8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Propanc Biopharma retires final convertible note via full conversion to common stock","bullets":["Retired final convertible promissory note dated June 30, 2022, with 1800 Diagonal Lending LLC.","Full payment made on Feb 15, 2023, converting all outstanding principal and interest into common stock.","Zero balance remaining; no further obligations to issue securities to the holder.","No specific financial impact or conversion terms disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-005757","json":"https://secwatch.observer/filing/0001493152-23-005757.json","markdown":"https://secwatch.observer/filing/0001493152-23-005757.md","text":"https://secwatch.observer/filing/0001493152-23-005757.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315223005757/0001493152-23-005757-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315223005757/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T04:44:31.813607+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}